Back to Results
First PageMeta Content
Health / Drug safety / Food and Drug Administration / Drugs / Drug Price Competition and Patent Term Restoration Act / New Drug Application / Over-the-counter drug / Pharmaceutical industry / Prescription medication / Pharmaceuticals policy / Pharmaceutical sciences / Pharmacology


OLSSON, PHILIP C. OLSSON RICHARD L. FRANK DAVID E WEEDA[removed]DENNIS R JOHNSON ARTHUR Y. TSIEN
Add to Reading List

Document Date: 2004-01-23 12:23:47

Open Document

File Size: 647,16 KB

Share Result on Facebook

City

Rockville / /

Company

PFab LP / Zeneca Ltd. / Abbott Labs. / Penney / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

approval applications / monograph systemfor prescription drug products / prescription drug products / prescription pharmaceuticals / particular products / individual applications / illegal products / generic pharmaceutical industry / pharmaceutical products / over-the-countersingle entity sustainedreleaseguaifenesin product / /

Organization

Congress / Branded Pharmaceutical Association / Food and Drug Administration / Division of Dockets Management / Committee on Appropriations / US Federal Reserve / House Committee / HAND-DELIVERED Division of Dockets Management / Center for Drug Evaluation / Committee on Health / Education / Labor / and Pensionsregarding / Senate / /

Person

D. BROOKS RYAN / BRETT T. SCHWEMER FRANKAND WEEDA / MARSHALL L. MATZ MICHAEL / JOHN W. BODE / PHILIP C. OLSSON RICHARD / FLAHERTY DAVID / STEPHEN D. TERMAN MARSHALL / DENNIS R JOHNSON / RYAN W. STROSCHEIN EVAN / RICHARD L. FRANK / FLAHERTY PAMELA J FURMAN / VALERIE B. SOLOMON / C. TISH E PAHL ROBERT / L. FRANK DAVID E WEEDA / PAMELA J FURMAN BRETT / ARTHUR Y. TSIEN JOHN / DAVID L. DURKIN NEIL / SHARON D. BROOKS / JOHNSON ARTHUR / L. LACEY SHARON / ROBERT A HAHN NAOMI / /

/

Position

LCDurkin Counsel / COUNSEL / Director / /

Product

digoxin / levothyroxine sodium / PRESCRIPTION DRUG / New Drug / 02P-0483 / /

ProvinceOrState

Maryland / /

SocialTag